Vistagen Therapeutics, Inc. · NASDAQ:VTGN

Orbimed Advisors LLC reported a 5.34% stake in Vistagen Therapeutics, Inc. (Schedule 13G)

Event Sep 30, 2025 · Filed Nov 14, 2025

Orbimed Advisors LLC reported a 5.34% stake in Vistagen Therapeutics, Inc., 1,639,700 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G).

Stake
5.34%
Shares
1,639,700
Intent
Passive
What changed
Crossed above 5%
Filed together
2 holders

The filing in full

HolderStakeShares
ORBIMED ADVISORS LLC4.63%1,420,300
ORBIMED CAPITAL LLC5.34%1,639,700

Source

View original at SEC

Related